GERN FY 2011 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-31.6% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$96M-3942.4% margin

Net Income

-$97M-3972.6% margin

EPS (Diluted)

$-0.78

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$63M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$160M

Total Liabilities

$13M

Stockholders' Equity

$147M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-31.6%
Gross Profit	$2M	$4M	-31.6%
Operating Income	-$96M	-$111M	+13.5%
Net Income	-$97M	-$111M	+13.0%